NET CONNECT has summarised highlights from ASCO 2020, AACR 2020 and WCGIC 2020 virtual meetings for you. Highlights from the abstracts: Efficacy and safety of surufatinib (ASCO), AGITG control NET Study (ASCO), DNA-PK inhibitor, M3814 (AACR) and Young adults with neuroendocrine tumours present high rate of pathogenic germline variants in cancer predisposing genes (WCGIC) by Dr Aman Chauhan, University of Kentucky’s Markey Cancer Center, (NCI Designated Cancer Center), Kentucky, USA

Aman Chauhan, MD, earned his medical degree from the Kasturba Medical College in Manipal, Karnataka, India, followed by a dual residency in internal medicine and pediatrics at Louisiana State University in New Orleans. Dr. Chauhan completed his fellowship in hematology and oncology at the University of Kentucky, especially focusing on neuroendocrine tumor (NETs). Additionally, Dr. Chauhan completed a Cancer Therapy Evaluation Program (CTEP) physician externship at the National Cancer institute (NCI) that focused on designing clinical trials and clinical research projects.

His clinical interests include treating NETs, including carcinoid tumors, high-grade neuroendocrine carcinomas, and small and large cell neuroendocrine carcinoma. Dr Chauhan leads the University of Miami Neuroendocrine Cancer Program and co-leads Sylvester Theranostics Drug Development Program. He is national principal investigator on several investigator initiated neuroendocrine cancer clinical trials. He has authored over 70 scientific publications and book chapters and has received career development award from NCI CTEP. Dr Chauhan also serves on AJCC and ASCO NET guideline committees and is an active member of NANETS communication committee.

Dr. Chauhan is board certified in internal medicine and medical oncology. He is a member of the American Society of Clinical Oncology as well as the American Association of Cancer Research and the North American Neuroendocrine Tumor Society.

Programme summary
Watch the video now
Share this programme
Supporter Acknowledgement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
NET CONNECT

NET CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen and from Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

podcast Podcast

Episode

of

episode
  • clock 19 MIN
  • calendar Jul 2024

this xxx bayer
conference-update Conference update
Oncology 
ASCO 2024 highlights

Experts
Prof. Shaheenah Dawood
Endorsed by
Bayer
  • download Downloadable
    Resources
  • clock 03 MIN
  • calendar Jul 2024

podcast Podcast
Hemostasis and bleeding disorders Oncology 
Cancer and Thrombosis

A podcast discussion on treating thrombosis in patients with cancer

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis
  • download Downloadable
    Resources
  • clock 14 MIN
  • calendar Sep 2023

Brought to you by COR2ED Medical Affairs in collaboration with Viatris.
Oncology 
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer

An interactive patient case video series from breast cancer specialists

Experts
Dr Elisa Agostinetto, Prof. Valentina Guarneri
Endorsed by
GRASP
  • clock 15 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology
publication Publication
Oncology  Patient Support
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023

Data from an Asia-Pacific patient and HCP survey

Experts
Prof. Chee-Kiat Tan
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Roche.
video Video
Oncology 
Long-term Response in Advanced Colorectal Cancer

A video update from Prof. Gerald Prager

Experts
Assoc. Prof. Gerald Prager
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Bayer.